HALO Diagnostics Stock

halodx.comHealthcare / Medical DevicesFounded: 2016

Halo Diagnostics' precision diagnostics focuses on the early detection of disease. Halo utilizes full-body imaging, genetic insights, and cell-level analysis to determine the overall risk of disease and prevention methods. Halo Diagnostics was founded in 2016 by Brian Axe and Michael Uhl and is headquartered in Indian Wells, CA.

Register for Details

For more details on financing and valuation for HALO Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for HALO Diagnostics.

Register Today

HALO Diagnostics investors also invested in these private companies

Team

Management Team

Gabriel Sanchez
Chief Strategy Officer
Aram Compeau
Chief Technology Officer
Cory Hammond
Chief Accounting Officer
Brian Axe
Co-Founder & Chief Product Officer
Chris Emery
Chief Business Officer
Kyle Fromm
Chief Compliance and Privacy Officer
Bernadette Greenwood
Chief Research Officer
John Feller
Chief Medical Officer
Michael Uhl
Co-Founder, Chief Executive Officer & Managing Partner

Other companies like HALO Diagnostics in the Medical Devices sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$263MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$943.68MM
Sector
Last Round Est. Valuation
$403.11MM
Sector
Last Round Est. Valuation
$1.35B
Sector
Last Round Est. Valuation
$893.88MM

News Highlights

Halo and Ikonopedia partner to provide genetic testing for breast cancer
Halo Diagnostics has announced a partnership with Ikonopedia, a breast imaging reporting and tracking solution, to offer genetic testing for breast cancer.
Updated on: Oct 1, 2023